BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 24844855)

  • 1. [Health technology assessment (HTA). Developments in healthcare and potential for radiology].
    Gizewski ER; Forsting M; Krombach GA; Schöffski O
    Radiologe; 2014 Jun; 54(6):589-98. PubMed ID: 24844855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health Technology Assessments in Radiology in Germany: Lack of Demand, Lack of Supply.
    Winkelmann C; Neumann T; Zeidler J; Prenzler A; Vogt B; Wacker FK
    Rofo; 2019 Jul; 191(7):635-642. PubMed ID: 30763963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Health economics and HTA].
    Kulp W; Greiner W
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Mar; 49(3):257-63. PubMed ID: 16465516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approaches for economic evaluations of health care technologies.
    Tarride JE; Blackhouse G; Bischof M; McCarron EC; Lim M; Ferrusi IL; Xie F; Goeree R
    J Am Coll Radiol; 2009 May; 6(5):307-16. PubMed ID: 19394571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resource modelling: the missing piece of the HTA jigsaw?
    Thokala P; Dixon S; Jahn B
    Pharmacoeconomics; 2015 Mar; 33(3):193-203. PubMed ID: 25411095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based decision-making 3: Health technology assessment.
    O'Reilly D; Campbell K; Vanstone M; Bowen JM; Schwartz L; Assasi N; Goeree R
    Methods Mol Biol; 2015; 1281():417-41. PubMed ID: 25694325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Use of MCDA in HTA: Great Potential, but More Effort Needed.
    Marsh KD; Sculpher M; Caro JJ; Tervonen T
    Value Health; 2018 Apr; 21(4):394-397. PubMed ID: 29680094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods of international health technology assessment agencies for economic evaluations--a comparative analysis.
    Mathes T; Jacobs E; Morfeld JC; Pieper D
    BMC Health Serv Res; 2013 Sep; 13():371. PubMed ID: 24079858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strengthening cost-effectiveness analysis in Thailand through the establishment of the health intervention and technology assessment program.
    Tantivess S; Teerawattananon Y; Mills A
    Pharmacoeconomics; 2009; 27(11):931-45. PubMed ID: 19888793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in Health Technology Assessment Recommendations Among European Jurisdictions: The Role of Practice Variations.
    Vreman RA; Mantel-Teeuwisse AK; Hövels AM; Leufkens HGM; Goettsch WG
    Value Health; 2020 Jan; 23(1):10-16. PubMed ID: 31952664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation in a disconnected healthcare system: problems and suggested solutions from the Australian HTA review.
    Gallego G; Harris A
    Expert Rev Pharmacoecon Outcomes Res; 2010 Dec; 10(6):615-7. PubMed ID: 21155692
    [No Abstract]   [Full Text] [Related]  

  • 12. Economic data transferability for HTA: are we there yet?
    Manca A
    Value Health; 2009 Jun; 12(4):407. PubMed ID: 19900247
    [No Abstract]   [Full Text] [Related]  

  • 13. Health technology assessment for radiologists: basic principles and evaluation framework.
    Lim ME; O'Reilly D; Tarride JE; Burke N; Ferrusi IL; Campbell K; Goeree R
    J Am Coll Radiol; 2009 May; 6(5):299-306. PubMed ID: 19394570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Informative value of Patient Reported Outcomes (PRO) in Health Technology Assessment (HTA).
    Brettschneider C; Lühmann D; Raspe H
    GMS Health Technol Assess; 2011 Feb; 7():Doc01. PubMed ID: 21468289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Over-, under- and misuse of pain treatment in Germany.
    Dietl M; Korczak D
    GMS Health Technol Assess; 2011 Apr; 7():Doc03. PubMed ID: 21522485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An International Review of Health Technology Assessment Approaches to Prescription Drugs and Their Ethical Principles.
    Rand LZ; Kesselheim AS
    J Law Med Ethics; 2020 Sep; 48(3):583-594. PubMed ID: 33021189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Culture, Values, and Politics in the Implementation of Health Technology Assessment in India: A Commentary.
    Swami S; Srivastava T
    Value Health; 2020 Jan; 23(1):39-42. PubMed ID: 31952672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'HTA for Crisis': sharing experiences during the 7th EBHC Symposium.
    Wladysiuk M; Tabor A; Godman B
    Expert Rev Pharmacoecon Outcomes Res; 2013 Feb; 13(1):47-9. PubMed ID: 23402445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A regulatory governance perspective on health technology assessment (HTA) in France: the contextual mediation of common functional pressures.
    Barron AJ; Klinger C; Shah SM; Wright JS
    Health Policy; 2015 Feb; 119(2):137-46. PubMed ID: 25458970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conditionally funded field evaluations and practical trial design within a health technology assessment framework.
    Bowen JM; Patterson LL; O'Reilly D; Hopkins RB; Blackhouse G; Burke N; Xie F; Tarride JE; Goeree R
    J Am Coll Radiol; 2009 May; 6(5):324-31. PubMed ID: 19394573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.